
Opinion|Videos|December 19, 2024
Advantages of the molecular structure of aflibercept
Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Aflibercept 2 mg is considered the standard of care for retinal vascular diseases. Can you briefly explain the structure of the aflibercept molecule and its significance?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Revakinagene taroretcel-lwey for MacTel: Charles Wykoff, MD, PhD, on a year of real-world experience
2
Vaccinated patients show markedly lower risk of new-onset idiopathic uveitis
3
Optimizing anti-VEGF in AMD, DME, and RVO: Strategies for durable disease control
4
Phase 3 data support OTX-TKI’s durability in wet AMD: 1 injection, 1 year
5























